Li, Cuifang
Wu, Feifeng
Mao, Jueyi
Wang, Yang
Zhu, Junquan
Hong, Kimsor
Xie, Haotian
Zhou, Xin
Tian, Jidong
Wen, Chuan http://orcid.org/0000-0001-6955-670X
Funding for this research was provided by:
National Natural Science Foundation of China (No. 82070758)
Health Commission of Hunan Province (No. 202206012608)
Article History
Received: 4 March 2024
Accepted: 5 July 2024
First Online: 18 July 2024
Declarations
:
: The experiment titled ‘Study on the Mechanism of MSC-EV-Mediated miRNA-145 Transfer in Regulating Th17/Treg Differentiation and Its Therapeutic Effects on SLE’ involves animal experimentation and has been approved by the Ethics Committee of the Second Xiangya Hospital, Central South University. The Ethics Committee approved this experimental project on September 1, 2022, with the approval number 20220161. All experimental procedures will strictly adhere to the approved documents of the Ethics Committee, ensuring proper care of the animals and compliance with animal welfare regulations.
: Not applicable.
: The authors declare that they have no competing interests.
: Not applicable.
: Not applicable.